Biological subtype, treatment response and outcomes in inflammatory breast cancer using data from the National Cancer Database.
A R KupstasT L HoskinC N DayJ C BougheyE B HabermannTina J HiekenPublished in: The British journal of surgery (2020)
Both treatment response and survival in patients with IBC varied with approximated biological subtype, as among other invasive breast cancers. These data support continued tailoring of systemic treatment to approximated biological subtype and highlight the recent improved outcomes in patients with HER2+ disease.